Relizorb

— THERAPEUTIC CATEGORIES —
  • Digestive and biliary disorders

Relizorb Generic Name & Formulations

General Description

Immobilized lipase (iLipase); per cartridge.

Pharmacological Class

Digestive enzymes.

How Supplied

Single-use cartridge—1

Generic Availability

NO

Relizorb Indications

Indications

To hydrolyze fats in enteral formula in patients ≥5yrs.

Relizorb Dosage and Administration

Adults and Children

<5yrs: not established. ≥5yrs: use with enteral pump flow rates 24–120mL/hr. Use 1 cartridge for up to 500mL of enteral formula; if formula volume >500mL, may install a second cartridge for use immediately; max 2 cartridges per 24hr period. If formula volume <500mL per feeding, discard cartridge after use. For compatible enteral formulas, pumps, feed sets, and pump extension sets: see full labeling.

Relizorb Contraindications

Not Applicable

Relizorb Boxed Warnings

Not Applicable

Relizorb Warnings/Precautions

Warnings/Precautions

For use with enteral feeding only. Do not connect to any IV line, set up, or system. Do not reuse. Not for use with gravity feed systems. Monitor patients with fibrosing colonopathy; may progress to stricture formation. Exocrine pancreatic insufficiency: not studied.

Relizorb Pharmacokinetics

See Literature

Relizorb Interactions

Interactions

Avoid enteral formulas containing insoluble fiber. Do not administer or add other medications through the cartridge or to the enteral feed line (in between the pump and cartridge). Concomitant porcine pancreatic enzyme replacement therapy: not studied.

Relizorb Adverse Reactions

Not Applicable

Relizorb Clinical Trials

See Literature

Relizorb Note

Not Applicable

Relizorb Patient Counseling

See Literature

Images